PET scan study of lung inflammation in never or current smokers
Part of Infections, Lungs & breathing clinical trials.
This early research study uses special PET scans to look at lung inflammation linked to a target called CCR2. It may help researchers understand inflammation biology and future treatments, using scan results instead of an investigational drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 or older.
- You are either a never-smoker, or a current smoker who smoked at least 10 cigarettes per day for the past month, with at least 100 cigarettes total in the last month.
- You can do about 1 hour of lying still during PET/CT or PET/MR, and follow the breathing instructions during the CT part.
- You have not used illicit drugs or other inhaled drug agents in the past year.
- You do not have known history of heart, lung, liver, or kidney disease, and you do not have diabetes.
- Your BMI is 35 or lower, and you are not pregnant (a urine test may be done).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether a special PET scan can detect a specific inflammation signal (CCR2) in atherosclerosis—fatty plaque buildup in blood vessels. It may help future doctors better see which plaques are more inflamed and potentially more dangerous.
This trial compares a new type of imaging scan (SPECT/CT) to the standard PET/CT scan to see if it can help diagnose and monitor lung cancer just as well. If you have lung cancer and are about to start treatment, you may be able to join to help test this new method.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study tests a special MRI scan that uses a “hyperpolarized” gas to look at how well the lungs are working. It’s likely looking for safe imaging results and clear lung measurements in people without lung disease.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
Hear when a new Lung Inflammation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.